FIBROSTENOTIC CROHN'S DISEASE
Clinical trials for FIBROSTENOTIC CROHN'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new FIBROSTENOTIC CROHN'S DISEASE trials appear
Sign up with your email to follow new studies for FIBROSTENOTIC CROHN'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could help Crohn's patients avoid bowel surgery
Disease control OngoingThis study tests a new drug called AGMB-129 in about 100 people with Crohn's disease who have painful bowel narrowing (strictures). The goal is to see if the drug is safe and can reduce the need for surgery. Participants receive either the drug or a placebo for 12 weeks, with an …
Matched conditions: FIBROSTENOTIC CROHN'S DISEASE
Phase: PHASE2 • Sponsor: Agomab Spain S.L.U. • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
New drug PALI-2108 studied for Crohn's scarring
Knowledge-focused OngoingThis study tests an experimental drug called PALI-2108 in 6 adults with fibrostenotic Crohn's disease, a condition where the gut becomes scarred and narrow. Participants take the drug for 14 days, and researchers analyze tissue samples to see how it affects inflammation and scarr…
Matched conditions: FIBROSTENOTIC CROHN'S DISEASE
Phase: PHASE1 • Sponsor: Palisade Bio • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:35 UTC